GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India · Delayed Price · Currency is INR 2,880.00
+6.40 (0.22%)
Sep 23, 2026, 3:30 PM IST
NSE:GLAXO Market Cap
NSE:GLAXO has a market cap or net worth of 486.45 billion as of September 23, 2026. Its market cap has increased by 4.00% in one year.
Market Cap
486.45B
Enterprise Value
459.21B
Revenue
39.55B
Ranking
n/a
PE Ratio
45.54
Stock Price
2,880.00
ChartMarket Cap Chart
Since October 25, 2001, NSE:GLAXO's market cap has increased from 19.14B to 486.45B, an increase of 2,441.52%. That is a compound annual growth rate of 13.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 487.30B | 16.41% |
| Dec 31, 2025 | 418.59B | 9.72% |
| Dec 31, 2024 | 381.50B | 18.69% |
| Dec 29, 2023 | 321.43B | 43.86% |
| Dec 30, 2022 | 223.43B | -25.08% |
| Dec 31, 2021 | 298.24B | 8.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 289.86B |
| Pfizer | 183.10B |
| Marksans Pharma | 145.08B |
| CORONA Remedies | 134.66B |
| Sanofi Consumer Healthcare India | 92.89B |
| Senores Pharmaceuticals | 64.59B |
| SMS Pharmaceuticals | 41.48B |
| Sai Parenteral's | 22.56B |